Literature DB >> 17504657

Eosinophils and asthma.

Elizabeth A Jacobsen1, Sergei I Ochkur, Nancy A Lee, James J Lee.   

Abstract

Recruitment and activation of eosinophils into the airways of asthma patients is suggested to be a contributing causative agent in the histopathologies and lung dysfunction that are characteristic of asthma. Recent studies in mouse models of asthma and in human patients implicate eosinophils in immune regulation and remodeling in the lung in addition to their hypothesized role as destructive agents. Specifically, eosinophils not only participate in release of granule proteins, lipid mediators, reactive oxygen species, cytokines, and growth factors but also function through complex cell-cell interactions to elicit chronic T helper 2 inflammation in the lung. This review highlights the roles of eosinophils in asthma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504657     DOI: 10.1007/s11882-007-0026-y

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  71 in total

Review 1.  Eosinophil trafficking in asthma.

Authors:  A J Wardlaw
Journal:  Clin Med (Lond)       Date:  2001 May-Jun       Impact factor: 2.659

2.  Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction.

Authors:  Allison D Fryer; Louis H Stein; Zhenying Nie; Damian E Curtis; Christopher M Evans; Simon T Hodgson; Peter J Jose; Kristen E Belmonte; Erin Fitch; David B Jacoby
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

3.  Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients.

Authors:  Masaru Fujii; Hiroshi Tanaka; Shosaku Abe
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

4.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Jacob A Thompson; Jian-Guo Geng; Nigel S Key; Arne Slungaard
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

5.  Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice.

Authors:  David S Southam; Natasha Widmer; Russ Ellis; Jeremy A Hirota; Mark D Inman; Roma Sehmi
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

6.  Increased biosynthesis of platelet-activating factor in activated human eosinophils.

Authors:  T Lee; D J Lenihan; B Malone; L L Roddy; S I Wasserman
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

7.  Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils.

Authors:  Anna-Lena Stenfeldt; Christine Wennerås
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

8.  CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma.

Authors:  Omid Akbari; John L Faul; Elisabeth G Hoyte; Gerald J Berry; Jan Wahlström; Mitchell Kronenberg; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  N Engl J Med       Date:  2006-03-16       Impact factor: 91.245

9.  Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein.

Authors:  M D Haskell; J N Moy; G J Gleich; L L Thomas
Journal:  Blood       Date:  1995-12-15       Impact factor: 22.113

10.  The ECP/Eo count ratio in children with asthma.

Authors:  Iwona Stelmach; Pawel Majak; Tomasz Grzelewski; Joanna Jerzynska; Dorota Jurałowicz; Wlodzimierz Stelmach; Malgorzata Borzecka-Podsiadlowicz; Aleksandra Korzeniewska; Piotr Kuna
Journal:  J Asthma       Date:  2004-08       Impact factor: 2.515

View more
  29 in total

1.  Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

Authors:  Jorge L Medina; Jacqueline J Coalson; Edward G Brooks; Vicki T Winter; Adriana Chaparro; Molly F R Principe; Thirumalai R Kannan; Joel B Baseman; Peter H Dube
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

Review 2.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.

Authors:  Seema S Aceves; Steven J Ackerman
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

Review 3.  Adenosine receptors and asthma.

Authors:  Constance N Wilson; Ahmed Nadeem; Domenico Spina; Rachel Brown; Clive P Page; S Jamal Mustafa
Journal:  Handb Exp Pharmacol       Date:  2009

4.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation.

Authors:  C Edward Rose; Joanne A Lannigan; Paul Kim; James J Lee; Shu Man Fu; Sun-sang J Sung
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

5.  Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation.

Authors:  Mehrab Nasirikenari; E V Chandrasekaran; Khushi L Matta; Brahm H Segal; Paul N Bogner; Amit A Lugade; Yasmin Thanavala; James J Lee; Joseph T Y Lau
Journal:  J Leukoc Biol       Date:  2009-12-09       Impact factor: 4.962

Review 6.  Mast cells and eosinophils: the two key effector cells in allergic inflammation.

Authors:  Yael Minai-Fleminger; Francesca Levi-Schaffer
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

7.  Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain.

Authors:  Jamie R Doyle; Subrahmanian T Krishnaji; Guangli Zhu; Zhen-Zhong Xu; Daniel Heller; Ru-Rong Ji; Bruce D Levy; Krishna Kumar; Alan S Kopin
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

Review 8.  Eosinophil-derived neurotoxin / RNase 2: connecting the past, the present and the future.

Authors:  H F Rosenberg
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

9.  Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow.

Authors:  Kimberly D Dyer; Jennifer M Moser; Meggan Czapiga; Steven J Siegel; Caroline M Percopo; Helene F Rosenberg
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 10.  Respiratory viruses and eosinophils: exploring the connections.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.